Cargando…

98. Outcomes of Clinical Decision Support for Outpatient Management of Clostridioides difficile Infection

BACKGROUND: Our antimicrobial stewardship program identified high rates of suboptimal metronidazole prescribing for Clostridioides difficile infection (CDI) within ambulatory clinics. An outpatient best practice advisory (BPA) was implemented to notify prescribers “Vancomycin or fidaxomicin are pref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Tiffany, Davis, Susan L, Church, Brian, Alangaden, George J, Kenney, Rachel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644800/ http://dx.doi.org/10.1093/ofid/ofab466.300

Ejemplares similares

62. Secondary Prophylaxis in Clostridioides difficile Infections: a Closer Look at Outcomes
por: Rodriguez, Rubi, et al.
Publicado: (2021)

787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
por: Garey, Kevin W, et al.
Publicado: (2020)

1019. Treatment Outcomes for Enterococcus faecium Bacteremia in Solid-Organ Transplant Patients: Implications for Daptomycin
por: Mercuro, Nicholas J, et al.
Publicado: (2018)

71. Diagnostic Stewardship of Clostridioides difficile Testing
por: Qamar, Zahra, et al.
Publicado: (2021)

88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric
por: Hussain, Cory, et al.
Publicado: (2020)

390. Eravacycline combination therapy for severe, recurrent, or fulminant Clostridioides difficile infection
por: Morrison, Austin R, et al.
Publicado: (2022)

2043. T2-Candida (T2MR) vs. Β-D-Glucan (BDG) for Preemptive Antifungal Stewardship in the Intensive Care Unit (ICU)
por: Gill, Christian, et al.
Publicado: (2018)

505. Bezlotoxumab Reduces Recurrence of Clostridium difficile Infection in Immunocompromised Patients: Early Experience at a Tertiary Care Center
por: Askar, Sally, et al.
Publicado: (2018)

1197. Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth
por: Alnezary, Faris, et al.
Publicado: (2020)

783. Clostridioides difficile Infection among Maintenance Hemodialysis Patients
por: Radhakrishnan, Parvathi, et al.
Publicado: (2020)

755. Clostridioides difficile Testing and the Use of Laxatives in Immunocompromised Adults
por: Al-Bahou, Amanda, et al.
Publicado: (2021)

192. More Low-hanging Fruit: Antibiotic Chelation Drug Interactions
por: Kenney, Rachel M, et al.
Publicado: (2018)

784. A Novel Method to Assess Virulence of Clostridioides difficile: Focus on C. difficile Ribotype 106
por: Almutairi, Masaad, et al.
Publicado: (2020)

147. Antibiotic Prescribing: Shorter is Also Better in the Emergency Department
por: Vuong, Lisa, et al.
Publicado: (2021)

1416. Assessing the potential for interspecies transmission of Clostridioides difficile on dairy farms
por: Redding, Laurel, et al.
Publicado: (2020)

12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations
por: Lawrence, Jody, et al.
Publicado: (2020)

801. Patients with Clostridioides difficile Infection Following Dental Antibiotic Prescription
por: Wilson, Geneva M, et al.
Publicado: (2020)

675. Evaluation of PLST for Clostridioides difficile Sequence-based Strain Typing
por: Edlind, Tom, et al.
Publicado: (2020)

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality
por: Sahrmann, John, et al.
Publicado: (2021)

782. Clostridioides difficile environmental contamination in hospitalized patients with diarrhea: a pilot study
por: Warren, Bobby G, et al.
Publicado: (2020)

1001. Chronic Colonization with Toxigenic Clostridioides difficile Strains Drives Colonic Tumorigenesis in Mice
por: Drewes, Julia L, et al.
Publicado: (2021)

751. Impact of Changing from a Three-step to Two-step Testing Algorithm for the Diagnosis of Clostridioides difficile
por: Lapin, Jonathan, et al.
Publicado: (2021)

391. Outcomes of Empiric Antimicrobial Therapy in COVID-19 Positive Patients
por: Medler, Corey J, et al.
Publicado: (2020)

722. Effectiveness of Fidaxomicin versus Oral Vancomycin in the Treatment of Recurrent Clostridioides difficile
por: Rinaldi, Alyssa, et al.
Publicado: (2020)

104. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Bettger, Caitlin C, et al.
Publicado: (2020)

804. Use of a Trained Canine to Detect Clostridioides difficile in the Hospital Environment
por: Harrison, Rachael M, et al.
Publicado: (2020)

740. Elucidation of the Mode of Clostridioides difficile Transmission Based on One Health Approach
por: Yoshizawa, Sadako, et al.
Publicado: (2021)

799. Mini Root Cause Analysis Reveals Opportunities for Reducing Clostridioides difficile Infection Rates
por: Turner, Nicholas A, et al.
Publicado: (2020)

772. Access Denied: Impact of Insurance Denials for High-Cost Outpatient Parenteral Antimicrobial Therapy
por: Bianchini, Monica L, et al.
Publicado: (2019)

182. Missed Opportunities to Discontinue Unnecessary Vancomycin During Pharmacist Therapeutic Monitoring
por: Medler, Corey J, et al.
Publicado: (2020)

754. A Two-step Testing Algorithm for Hospital-onset Clostridioides difficile Infection (CDI) Reduces Prescribing of C. difficile (CD) Therapy but Its Ability to Guide Treatment Decisions Remains Unclear
por: Dolan, Mackenzie, et al.
Publicado: (2021)

796. Improving Clostridioides difficile Infection Treatment and Outcomes Using a Web-based Tool to Support a Care Coordination Intervention
por: McKoy, J Nikki, et al.
Publicado: (2020)

729. Real World Efficacy of Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Immunosuppressed Patients
por: Perreault, Sarah, et al.
Publicado: (2020)

1376. Oral Vancomycin as Secondary Prophylaxis Against Clostridioides difficile Infection in Pediatric Patients
por: Bao, Hongkai, et al.
Publicado: (2020)

875. Pseudo-outbreak of Clostridioides (Clostridium) difficile amongst post-operative Oncology Patients
por: Kagedan, Daniel, et al.
Publicado: (2020)

P26 Phenotypic and genotypic characterization of antimicrobial resistance in Clostridioides difficile in North Wales
por: Thomas, R., et al.
Publicado: (2022)

1037. Efficacy of Germinants and Omadacycline for Preventing Clostridioides difficile Relapse in a Murine Model
por: Budi, Noah, et al.
Publicado: (2021)

56. High Frequencies of Adverse Drug Events with Intravenous vs Oral High-Dose Trimethoprim-Sulfamethoxazole: An Opportunity for Antibiotic Stewardship
por: Vuong, Lisa, et al.
Publicado: (2021)

797. Management of Patients with Multiple Clostridioides difficile Infection Recurrences using a Tapered-Pulsed Fidaxomicin Strategy
por: Tan, Xing, et al.
Publicado: (2020)

2339. Clostridioides difficile: Impact of Active Screening of Asymptomatic Carriers and Testing Stewardship
por: Beth Graham, Mary, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9334bni4p7gdau7fe9kfup8tqg